Request for Covid-19 Impact Assessment of this Report
The United States Antiemetic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antiemetic Drugs market, reaching US$ million by the year 2028. As for the Europe Antiemetic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antiemetic Drugs players cover GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiemetic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chemotherapy
Gastroenteritis
Surgery
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antiemetic Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antiemetic Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antiemetic Drugs by Country/Region, 2017, 2022 & 2028
2.2 Antiemetic Drugs Segment by Type
2.2.1 Dopamine Antagonist
2.2.2 5-HT-3 Receptor Antagonist
2.2.3 NK1 Receptor Antagonist
2.2.4 Cannabinoid Receptor Antagonist
2.3 Antiemetic Drugs Sales by Type
2.3.1 Global Antiemetic Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Antiemetic Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antiemetic Drugs Sale Price by Type (2017-2022)
2.4 Antiemetic Drugs Segment by Application
2.4.1 Chemotherapy
2.4.2 Gastroenteritis
2.4.3 Surgery
2.5 Antiemetic Drugs Sales by Application
2.5.1 Global Antiemetic Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Antiemetic Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antiemetic Drugs Sale Price by Application (2017-2022)
3 Global Antiemetic Drugs by Company
3.1 Global Antiemetic Drugs Breakdown Data by Company
3.1.1 Global Antiemetic Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Antiemetic Drugs Sales Market Share by Company (2020-2022)
3.2 Global Antiemetic Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Antiemetic Drugs Revenue by Company (2020-2022)
3.2.2 Global Antiemetic Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Antiemetic Drugs Sale Price by Company
3.4 Key Manufacturers Antiemetic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antiemetic Drugs Product Location Distribution
3.4.2 Players Antiemetic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antiemetic Drugs by Geographic Region
4.1 World Historic Antiemetic Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Antiemetic Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antiemetic Drugs Annual Revenue by Geographic Region
4.2 World Historic Antiemetic Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Antiemetic Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antiemetic Drugs Annual Revenue by Country/Region
4.3 Americas Antiemetic Drugs Sales Growth
4.4 APAC Antiemetic Drugs Sales Growth
4.5 Europe Antiemetic Drugs Sales Growth
4.6 Middle East & Africa Antiemetic Drugs Sales Growth
5 Americas
5.1 Americas Antiemetic Drugs Sales by Country
5.1.1 Americas Antiemetic Drugs Sales by Country (2017-2022)
5.1.2 Americas Antiemetic Drugs Revenue by Country (2017-2022)
5.2 Americas Antiemetic Drugs Sales by Type
5.3 Americas Antiemetic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiemetic Drugs Sales by Region
6.1.1 APAC Antiemetic Drugs Sales by Region (2017-2022)
6.1.2 APAC Antiemetic Drugs Revenue by Region (2017-2022)
6.2 APAC Antiemetic Drugs Sales by Type
6.3 APAC Antiemetic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antiemetic Drugs by Country
7.1.1 Europe Antiemetic Drugs Sales by Country (2017-2022)
7.1.2 Europe Antiemetic Drugs Revenue by Country (2017-2022)
7.2 Europe Antiemetic Drugs Sales by Type
7.3 Europe Antiemetic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antiemetic Drugs by Country
8.1.1 Middle East & Africa Antiemetic Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antiemetic Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Antiemetic Drugs Sales by Type
8.3 Middle East & Africa Antiemetic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiemetic Drugs
10.3 Manufacturing Process Analysis of Antiemetic Drugs
10.4 Industry Chain Structure of Antiemetic Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antiemetic Drugs Distributors
11.3 Antiemetic Drugs Customer
12 World Forecast Review for Antiemetic Drugs by Geographic Region
12.1 Global Antiemetic Drugs Market Size Forecast by Region
12.1.1 Global Antiemetic Drugs Forecast by Region (2023-2028)
12.1.2 Global Antiemetic Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antiemetic Drugs Forecast by Type
12.7 Global Antiemetic Drugs Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Antiemetic Drugs Product Offered
13.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Antiemetic Drugs Product Offered
13.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Antiemetic Drugs Product Offered
13.3.3 Pfizer Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Antiemetic Drugs Product Offered
13.4.3 Sanofi Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Antiemetic Drugs Product Offered
13.5.3 Abbott Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Information
13.6.2 Bristol-Myers Squibb Antiemetic Drugs Product Offered
13.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bristol-Myers Squibb Main Business Overview
13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Antiemetic Drugs Product Offered
13.7.3 Cipla Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Eisai
13.8.1 Eisai Company Information
13.8.2 Eisai Antiemetic Drugs Product Offered
13.8.3 Eisai Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Eisai Main Business Overview
13.8.5 Eisai Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Antiemetic Drugs Product Offered
13.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Glenmark
13.10.1 Glenmark Company Information
13.10.2 Glenmark Antiemetic Drugs Product Offered
13.10.3 Glenmark Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Glenmark Main Business Overview
13.10.5 Glenmark Latest Developments
13.11 Helsinn Healthcare
13.11.1 Helsinn Healthcare Company Information
13.11.2 Helsinn Healthcare Antiemetic Drugs Product Offered
13.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Helsinn Healthcare Main Business Overview
13.11.5 Helsinn Healthcare Latest Developments
13.12 Heron Therapeutics
13.12.1 Heron Therapeutics Company Information
13.12.2 Heron Therapeutics Antiemetic Drugs Product Offered
13.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Heron Therapeutics Main Business Overview
13.12.5 Heron Therapeutics Latest Developments
13.13 IPCA Laboratories
13.13.1 IPCA Laboratories Company Information
13.13.2 IPCA Laboratories Antiemetic Drugs Product Offered
13.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 IPCA Laboratories Main Business Overview
13.13.5 IPCA Laboratories Latest Developments
13.14 Lupin
13.14.1 Lupin Company Information
13.14.2 Lupin Antiemetic Drugs Product Offered
13.14.3 Lupin Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Lupin Main Business Overview
13.14.5 Lupin Latest Developments
13.15 Merck
13.15.1 Merck Company Information
13.15.2 Merck Antiemetic Drugs Product Offered
13.15.3 Merck Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Merck Main Business Overview
13.15.5 Merck Latest Developments
13.16 Novartis
13.16.1 Novartis Company Information
13.16.2 Novartis Antiemetic Drugs Product Offered
13.16.3 Novartis Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Novartis Main Business Overview
13.16.5 Novartis Latest Developments
13.17 RedHill
13.17.1 RedHill Company Information
13.17.2 RedHill Antiemetic Drugs Product Offered
13.17.3 RedHill Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 RedHill Main Business Overview
13.17.5 RedHill Latest Developments
13.18 Sun Pharmaceutical Industries
13.18.1 Sun Pharmaceutical Industries Company Information
13.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Product Offered
13.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Sun Pharmaceutical Industries Main Business Overview
13.18.5 Sun Pharmaceutical Industries Latest Developments
13.19 Takeda Pharmaceutical
13.19.1 Takeda Pharmaceutical Company Information
13.19.2 Takeda Pharmaceutical Antiemetic Drugs Product Offered
13.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Takeda Pharmaceutical Main Business Overview
13.19.5 Takeda Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Antiemetic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antiemetic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Dopamine Antagonist
Table 4. Major Players of 5-HT-3 Receptor Antagonist
Table 5. Major Players of NK1 Receptor Antagonist
Table 6. Major Players of Cannabinoid Receptor Antagonist
Table 7. Global Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global Antiemetic Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Antiemetic Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Antiemetic Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Antiemetic Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global Antiemetic Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Antiemetic Drugs Revenue by Application (2017-2022)
Table 15. Global Antiemetic Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Antiemetic Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Antiemetic Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global Antiemetic Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Antiemetic Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Antiemetic Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Antiemetic Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Antiemetic Drugs Producing Area Distribution and Sales Area
Table 23. Players Antiemetic Drugs Products Offered
Table 24. Antiemetic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Antiemetic Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Antiemetic Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Antiemetic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Antiemetic Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Antiemetic Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Antiemetic Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Antiemetic Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Antiemetic Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Antiemetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Antiemetic Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas Antiemetic Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Antiemetic Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Antiemetic Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Antiemetic Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Antiemetic Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC Antiemetic Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Antiemetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Antiemetic Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe Antiemetic Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Antiemetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Antiemetic Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Antiemetic Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Antiemetic Drugs
Table 68. Key Market Challenges & Risks of Antiemetic Drugs
Table 69. Key Industry Trends of Antiemetic Drugs
Table 70. Antiemetic Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Antiemetic Drugs Distributors List
Table 73. Antiemetic Drugs Customer List
Table 74. Global Antiemetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Antiemetic Drugs Sales Market Forecast by Region
Table 76. Global Antiemetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Antiemetic Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Antiemetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Antiemetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Antiemetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Antiemetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Antiemetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Antiemetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Antiemetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Antiemetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Antiemetic Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Antiemetic Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Antiemetic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Antiemetic Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Antiemetic Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Antiemetic Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Antiemetic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Antiemetic Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. GlaxoSmithKline Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Antiemetic Drugs Product Offered
Table 96. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Johnson & Johnson Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Antiemetic Drugs Product Offered
Table 101. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Pfizer Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Antiemetic Drugs Product Offered
Table 106. Pfizer Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Sanofi Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanofi Antiemetic Drugs Product Offered
Table 111. Sanofi Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
Table 114. Abbott Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Abbott Antiemetic Drugs Product Offered
Table 116. Abbott Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Abbott Main Business
Table 118. Abbott Latest Developments
Table 119. Bristol-Myers Squibb Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol-Myers Squibb Antiemetic Drugs Product Offered
Table 121. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Bristol-Myers Squibb Main Business
Table 123. Bristol-Myers Squibb Latest Developments
Table 124. Cipla Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Cipla Antiemetic Drugs Product Offered
Table 126. Cipla Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Cipla Main Business
Table 128. Cipla Latest Developments
Table 129. Eisai Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Eisai Antiemetic Drugs Product Offered
Table 131. Eisai Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Eisai Main Business
Table 133. Eisai Latest Developments
Table 134. Eli Lilly Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Eli Lilly Antiemetic Drugs Product Offered
Table 136. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. Eli Lilly Main Business
Table 138. Eli Lilly Latest Developments
Table 139. Glenmark Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Glenmark Antiemetic Drugs Product Offered
Table 141. Glenmark Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. Glenmark Main Business
Table 143. Glenmark Latest Developments
Table 144. Helsinn Healthcare Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Helsinn Healthcare Antiemetic Drugs Product Offered
Table 146. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. Helsinn Healthcare Main Business
Table 148. Helsinn Healthcare Latest Developments
Table 149. Heron Therapeutics Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Heron Therapeutics Antiemetic Drugs Product Offered
Table 151. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 152. Heron Therapeutics Main Business
Table 153. Heron Therapeutics Latest Developments
Table 154. IPCA Laboratories Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. IPCA Laboratories Antiemetic Drugs Product Offered
Table 156. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 157. IPCA Laboratories Main Business
Table 158. IPCA Laboratories Latest Developments
Table 159. Lupin Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Lupin Antiemetic Drugs Product Offered
Table 161. Lupin Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 162. Lupin Main Business
Table 163. Lupin Latest Developments
Table 164. Merck Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 165. Merck Antiemetic Drugs Product Offered
Table 166. Merck Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 167. Merck Main Business
Table 168. Merck Latest Developments
Table 169. Novartis Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 170. Novartis Antiemetic Drugs Product Offered
Table 171. Novartis Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 172. Novartis Main Business
Table 173. Novartis Latest Developments
Table 174. RedHill Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 175. RedHill Antiemetic Drugs Product Offered
Table 176. RedHill Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 177. RedHill Main Business
Table 178. RedHill Latest Developments
Table 179. Sun Pharmaceutical Industries Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 180. Sun Pharmaceutical Industries Antiemetic Drugs Product Offered
Table 181. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 182. Sun Pharmaceutical Industries Main Business
Table 183. Sun Pharmaceutical Industries Latest Developments
Table 184. Takeda Pharmaceutical Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 185. Takeda Pharmaceutical Antiemetic Drugs Product Offered
Table 186. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 187. Takeda Pharmaceutical Main Business
Table 188. Takeda Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Antiemetic Drugs
Figure 2. Antiemetic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiemetic Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Antiemetic Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antiemetic Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Dopamine Antagonist
Figure 10. Product Picture of 5-HT-3 Receptor Antagonist
Figure 11. Product Picture of NK1 Receptor Antagonist
Figure 12. Product Picture of Cannabinoid Receptor Antagonist
Figure 13. Global Antiemetic Drugs Sales Market Share by Type in 2021
Figure 14. Global Antiemetic Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Antiemetic Drugs Consumed in Chemotherapy
Figure 16. Global Antiemetic Drugs Market: Chemotherapy (2017-2022) & (K Units)
Figure 17. Antiemetic Drugs Consumed in Gastroenteritis
Figure 18. Global Antiemetic Drugs Market: Gastroenteritis (2017-2022) & (K Units)
Figure 19. Antiemetic Drugs Consumed in Surgery
Figure 20. Global Antiemetic Drugs Market: Surgery (2017-2022) & (K Units)
Figure 21. Global Antiemetic Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Antiemetic Drugs Revenue Market Share by Application in 2021
Figure 23. Antiemetic Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Antiemetic Drugs Revenue Market Share by Company in 2021
Figure 25. Global Antiemetic Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Antiemetic Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Antiemetic Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Antiemetic Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Antiemetic Drugs Sales 2017-2022 (K Units)
Figure 30. Americas Antiemetic Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Antiemetic Drugs Sales 2017-2022 (K Units)
Figure 32. APAC Antiemetic Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Antiemetic Drugs Sales 2017-2022 (K Units)
Figure 34. Europe Antiemetic Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Antiemetic Drugs Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Antiemetic Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Antiemetic Drugs Sales Market Share by Country in 2021
Figure 38. Americas Antiemetic Drugs Revenue Market Share by Country in 2021
Figure 39. United States Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Antiemetic Drugs Sales Market Share by Region in 2021
Figure 44. APAC Antiemetic Drugs Revenue Market Share by Regions in 2021
Figure 45. China Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Antiemetic Drugs Sales Market Share by Country in 2021
Figure 52. Europe Antiemetic Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Antiemetic Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Antiemetic Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Antiemetic Drugs in 2021
Figure 66. Manufacturing Process Analysis of Antiemetic Drugs
Figure 67. Industry Chain Structure of Antiemetic Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...